MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

why the sell-off?, page-48

  1. 6,010 Posts.
    There is of course one problem.. If a group of patients know each other ( which is quite possible within the logistics of such a trial) and none of them notices any beneficial effcets, they can easily make assumptions and draw conclusions.

 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.